Jacobs Levy Equity Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $643K | Sell |
142,641
-94,870
| -40% | -$428K | ﹤0.01% | 833 |
|
|
2025
Q1 | $1.05M | Buy |
237,511
+87,830
| +59% | +$389K | ﹤0.01% | 800 |
|
|
2024
Q4 | $1.17M | Hold |
149,681
| – | – | ﹤0.01% | 692 |
|
|
2024
Q3 | $1.97M | Hold |
149,681
| – | – | 0.01% | 607 |
|
|
2024
Q2 | $1.81M | Sell |
149,681
-4,335
| -3% | -$52.4K | 0.01% | 622 |
|
|
2024
Q1 | $2.5M | Sell |
154,016
-98,904
| -39% | -$1.61M | 0.01% | 559 |
|
|
2023
Q4 | $1.72M | Sell |
252,920
-277,519
| -52% | -$1.89M | 0.01% | 626 |
|
|
2023
Q3 | $2.89M | Sell |
530,439
-34,092
| -6% | -$186K | 0.02% | 497 |
|
|
2023
Q2 | $3.83M | Buy |
564,531
+240,634
| +74% | +$1.63M | 0.02% | 455 |
|
|
2023
Q1 | $1.62M | Buy |
+323,897
| New | +$1.62M | 0.01% | 610 |
|